Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics

导出原文传递

翻译打印收藏纠错

作者： Yamasaki, Satoshi ^[1] ; Yoshimoto, Goichi ^[2] ; Ogawa, Ryosuke ^[3] ; Aoki, Kenichi ^[4] ; Higuchi, Masakazu ^[5] ; Harada, Naoki ^[6] ; Arima, Fumito ^[7] ; Kondo, Seiji ^[8] ; Matubara, Fujio ^[9] ; Takahashi, Tsutomu ^[10] ; Uike, Naokuni ; Miyamoto, Toshihiro ; Okamura, Seiichi ; Akashi, Koichi

作者单位： Natl Hosp Org, Dept Hematol, Kyushu Med Ctr, Chuo Ku, Fukuoka 8108563, Japan ^[1] Shin Kokura Hosp, Dept Hematol, Kitakyushu, Fukuoka, Japan ^[2] Chihaya Hosp, Dept Hematol, Fukuoka, Japan ^[3] Kyushu Hosp, Japan Community Hlth Care Org, Dept Hematol Oncol, Fukuoka, Japan ^[4] Koga Hosp, Dept Hematol, Kurume, Fukuoka, Japan ^[5] Saga Prefectural Hosp Koseikan, Dept Hematol, Saga, Japan ^[6] JR Kyushu Hosp, Dept Hematol, Kitakyushu, Fukuoka, Japan ^[7] Natl Hosp Org, Kyushu Canc Ctr, Dept Hematol, Fukuoka, Japan ^[8] Shimane Univ Hosp, Dept Hematol Oncol, Izumo, Shimane, Japan ^[9] Kyushu Univ Hosp, Dept Hematol Oncol, Fukuoka 812, Japan ^[10]

关键词 Older patients Acute myeloid leukemia First complete remission Reduced-intensity conditioning Allogeneic hematopoietic cell transplantation

发布时间 2015-09-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交